Pixie I am almost positive that the partial clinical hold is a result of an application by Prana for an expedited approval track for PBT2. Since this process is fairly new and it is an orphan drug, FDA employed the brakes to check the process down a bit IMO. There doesn't seem to be another reasonable explanation for FDA putting a clinical hold when the drug isn't in the clinic atm. I believe they are attempting to get this drug approved and not fund research forever. But that's my assessment. Be sure that there is a lot going on behind the scenes right now.
Prana - the street possible breakout, page-5
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $570 | 149.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 13513113 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130775819 | 29 |
View Market Depth
| Last trade - 15.46pm 27/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |